The stock of Nutex Health Inc. (NASDAQ:NUTX) last traded at $0.49, down -8.01% from the previous session.
Data from the available sources indicates that Nutex Health Inc. (NASDAQ:NUTX) is covered by 2 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $3.00 and a low of $2.50, we find $2.75. Given the previous closing price of $0.53, this indicates a potential upside of 418.87 percent. NUTX stock price is now -35.83% away from the 50-day moving average and -67.04% away from the 200-day moving average. The market capitalization of the company currently stands at $285.23M.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
In total, 0 analysts have assigned it a hold rating, and 2 have given it a buy rating. Brokers who have rated the stock have averaged $2.75 as their price target over the next twelve months.
.
In other news, Waters John J, Director bought 50,000 shares of the company’s stock on May 18. The stock was bought for $23,450 at an average price of $0.47. Upon completion of the transaction, the Director now directly owns 196,262 shares in the company, valued at $96168.38. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 13, 10% Owner Premier Macy Management Holdin sold 43,880 shares of the business’s stock. A total of $90,560 was realized by selling the stock at an average price of $2.06. This leaves the insider owning 41,964,832 shares of the company worth $20.56 million. Insiders disposed of 169,378 shares of company stock worth roughly $82995.22 over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in NUTX stock. A new stake in Nutex Health Inc. shares was purchased by BALYASNY ASSET MANAGEMENT L.P. during the first quarter worth $87,000. METLIFE INVESTMENT MANAGEMENT, LLC invested $67,000 in shares of NUTX during the first quarter. In the first quarter, SUSQUEHANNA INTERNATIONAL GROUP, LLP acquired a new stake in Nutex Health Inc. valued at approximately $51,000. WELLS FARGO & COMPANY/MN acquired a new stake in NUTX for approximately $23,000. VIRTU FINANCIAL LLC purchased a new stake in NUTX valued at around $23,000 in the second quarter. In total, there are 109 active investors with 1.30% ownership of the company’s stock.
With an opening price of $0.5299 on Wednesday morning, Nutex Health Inc. (NASDAQ: NUTX) set off the trading day. During the past 12 months, Nutex Health Inc. has had a low of $0.46 and a high of $11.19. As of last week, the company has a debt-to-equity ratio of 2.85, a current ratio of 1.90, and a quick ratio of 1.80. The fifty day moving average price for NUTX is $0.7493 and a two-hundred day moving average price translates $1.4678 for the stock.
The latest earnings results from Nutex Health Inc. (NASDAQ: NUTX) was released for Mar, 2023. According to the Health Information Services Company, earnings per share came in at -$0.01, inline with analysts’ expectations of -$0.01. This compares to $0.04 EPS in the same period last year. The company reported revenue of $56.33 million for the quarter, compared to $79.13 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -28.81 percent. For the current quarter, analysts expect NUTX to generate $62.05M in revenue.
Nutex Health Inc.(NUTX) Company Profile
Nutex Health Inc. operates as a network of micro-hospitals. It operates through three segments: Hospital, Population Health Management, and Real Estate. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. The Population Health Management segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment leases land and hospital building. It also provides healthcare and facility management services; and healthcare billing, coding, and collection services. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.
